The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer.

Podobne zapisy

• The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.
  od: Lønning, P. E., i wsp.
  Wydane: (1991)
• Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.
  od: MacNeill, F. A., i wsp.
  Wydane: (1994)
• Role of aminoglutethimide in male breast cancer.
  od: Harris, A. L., i wsp.
  Wydane: (1986)
• Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients.
  od: Dowsett, M., i wsp.
  Wydane: (1985)
• Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.
  od: Geisler, J., i wsp.
  Wydane: (1996)